Enteral nutrition: Enteral nutrition (EN) is a nutritional support method that provides nutrients needed for metabolism and various other nutrients through the gastrointestinal tract. It depends on the length of time, mental state and gastrointestinal function. There are two ways of enteral nutrition: oral and transcatheter input. Transcatheter input includes nasogastric tube, nasoduodenal tube, nasojejunal tube and gastrojejunostomy tube.
Parenteral nutrition: Parenteral nutrition (PN) is the supply of nutrients intravenously as nutritional support before and after surgery and for critically ill patients. All nutrition supplied from the parenteral source is called total parenteral nutrition (TPN).
The global Enteral Nutrition and Parenteral Nutrition market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Enteral Nutrition and Parenteral Nutrition Industry Forecast” looks at past sales and reviews total world Enteral Nutrition and Parenteral Nutrition sales in 2023, providing a comprehensive analysis by region and market sector of projected Enteral Nutrition and Parenteral Nutrition sales for 2024 through 2030. With Enteral Nutrition and Parenteral Nutrition sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enteral Nutrition and Parenteral Nutrition industry.
This Insight Report provides a comprehensive analysis of the global Enteral Nutrition and Parenteral Nutrition landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enteral Nutrition and Parenteral Nutrition portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enteral Nutrition and Parenteral Nutrition market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enteral Nutrition and Parenteral Nutrition and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enteral Nutrition and Parenteral Nutrition.
Increasing medical needs: As the global population ages and the incidence of chronic diseases increases, the number of patients requiring nutritional support continues to increase. Enteral and parenteral nutrition are important means of nutritional support, and their demand has also increased.
Technological progress: With the continuous advancement of medical technology, the formulas and delivery methods of enteral and parenteral nutrition have been optimized and improved, improving treatment effects and patient survival rates.
Clinical studies: A large number of clinical studies have provided more evidence and support for the application of enteral and parenteral nutrition. These studies not only confirm the effectiveness of enteral and parenteral nutrition in the treatment of various diseases, but also provide assurance for their safety.
This report presents a comprehensive overview, market shares, and growth opportunities of Enteral Nutrition and Parenteral Nutrition market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Oral/Tube Feeding
Intravenous Injection
Segmentation by application
Hospital Clinic
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
B. Braun
Baxter
BBCA Pharmaceutical
Biokin Pharmaceutical
China Meheco Kangli
Cisen
Danone
Fresenius Kabi
Grand Life Sciences
Haisco Pharmaceutical Group
JW Pharmaceutical
Kelun Pharma
King York
Lionco Pharmaceutical
Lummy
Medisan
Medtrition
Nestlé S.A.
Otsuka Pharmaceutical
Pfizer
Teva Pharmaceutical
Xi'an Libang Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enteral Nutrition and Parenteral Nutrition market?
What factors are driving Enteral Nutrition and Parenteral Nutrition market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enteral Nutrition and Parenteral Nutrition market opportunities vary by end market size?
How does Enteral Nutrition and Parenteral Nutrition break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Enteral Nutrition and Parenteral Nutrition Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Enteral Nutrition and Parenteral Nutrition by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Enteral Nutrition and Parenteral Nutrition by Country/Region, 2019, 2023 & 2030
2.2 Enteral Nutrition and Parenteral Nutrition Segment by Type
2.2.1 Oral/Tube Feeding
2.2.2 Intravenous Injection
2.3 Enteral Nutrition and Parenteral Nutrition Sales by Type
2.3.1 Global Enteral Nutrition and Parenteral Nutrition Sales Market Share by Type (2019-2024)
2.3.2 Global Enteral Nutrition and Parenteral Nutrition Revenue and Market Share by Type (2019-2024)
2.3.3 Global Enteral Nutrition and Parenteral Nutrition Sale Price by Type (2019-2024)
2.4 Enteral Nutrition and Parenteral Nutrition Segment by Application
2.4.1 Hospital Clinic
2.4.2 Pharmacy
2.4.3 Others
2.5 Enteral Nutrition and Parenteral Nutrition Sales by Application
2.5.1 Global Enteral Nutrition and Parenteral Nutrition Sale Market Share by Application (2019-2024)
2.5.2 Global Enteral Nutrition and Parenteral Nutrition Revenue and Market Share by Application (2019-2024)
2.5.3 Global Enteral Nutrition and Parenteral Nutrition Sale Price by Application (2019-2024)
3 Global Enteral Nutrition and Parenteral Nutrition by Company
3.1 Global Enteral Nutrition and Parenteral Nutrition Breakdown Data by Company
3.1.1 Global Enteral Nutrition and Parenteral Nutrition Annual Sales by Company (2019-2024)
3.1.2 Global Enteral Nutrition and Parenteral Nutrition Sales Market Share by Company (2019-2024)
3.2 Global Enteral Nutrition and Parenteral Nutrition Annual Revenue by Company (2019-2024)
3.2.1 Global Enteral Nutrition and Parenteral Nutrition Revenue by Company (2019-2024)
3.2.2 Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share by Company (2019-2024)
3.3 Global Enteral Nutrition and Parenteral Nutrition Sale Price by Company
3.4 Key Manufacturers Enteral Nutrition and Parenteral Nutrition Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enteral Nutrition and Parenteral Nutrition Product Location Distribution
3.4.2 Players Enteral Nutrition and Parenteral Nutrition Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Enteral Nutrition and Parenteral Nutrition by Geographic Region
4.1 World Historic Enteral Nutrition and Parenteral Nutrition Market Size by Geographic Region (2019-2024)
4.1.1 Global Enteral Nutrition and Parenteral Nutrition Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Enteral Nutrition and Parenteral Nutrition Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Enteral Nutrition and Parenteral Nutrition Market Size by Country/Region (2019-2024)
4.2.1 Global Enteral Nutrition and Parenteral Nutrition Annual Sales by Country/Region (2019-2024)
4.2.2 Global Enteral Nutrition and Parenteral Nutrition Annual Revenue by Country/Region (2019-2024)
4.3 Americas Enteral Nutrition and Parenteral Nutrition Sales Growth
4.4 APAC Enteral Nutrition and Parenteral Nutrition Sales Growth
4.5 Europe Enteral Nutrition and Parenteral Nutrition Sales Growth
4.6 Middle East & Africa Enteral Nutrition and Parenteral Nutrition Sales Growth
5 Americas
5.1 Americas Enteral Nutrition and Parenteral Nutrition Sales by Country
5.1.1 Americas Enteral Nutrition and Parenteral Nutrition Sales by Country (2019-2024)
5.1.2 Americas Enteral Nutrition and Parenteral Nutrition Revenue by Country (2019-2024)
5.2 Americas Enteral Nutrition and Parenteral Nutrition Sales by Type
5.3 Americas Enteral Nutrition and Parenteral Nutrition Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enteral Nutrition and Parenteral Nutrition Sales by Region
6.1.1 APAC Enteral Nutrition and Parenteral Nutrition Sales by Region (2019-2024)
6.1.2 APAC Enteral Nutrition and Parenteral Nutrition Revenue by Region (2019-2024)
6.2 APAC Enteral Nutrition and Parenteral Nutrition Sales by Type
6.3 APAC Enteral Nutrition and Parenteral Nutrition Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Enteral Nutrition and Parenteral Nutrition by Country
7.1.1 Europe Enteral Nutrition and Parenteral Nutrition Sales by Country (2019-2024)
7.1.2 Europe Enteral Nutrition and Parenteral Nutrition Revenue by Country (2019-2024)
7.2 Europe Enteral Nutrition and Parenteral Nutrition Sales by Type
7.3 Europe Enteral Nutrition and Parenteral Nutrition Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Enteral Nutrition and Parenteral Nutrition by Country
8.1.1 Middle East & Africa Enteral Nutrition and Parenteral Nutrition Sales by Country (2019-2024)
8.1.2 Middle East & Africa Enteral Nutrition and Parenteral Nutrition Revenue by Country (2019-2024)
8.2 Middle East & Africa Enteral Nutrition and Parenteral Nutrition Sales by Type
8.3 Middle East & Africa Enteral Nutrition and Parenteral Nutrition Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enteral Nutrition and Parenteral Nutrition
10.3 Manufacturing Process Analysis of Enteral Nutrition and Parenteral Nutrition
10.4 Industry Chain Structure of Enteral Nutrition and Parenteral Nutrition
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enteral Nutrition and Parenteral Nutrition Distributors
11.3 Enteral Nutrition and Parenteral Nutrition Customer
12 World Forecast Review for Enteral Nutrition and Parenteral Nutrition by Geographic Region
12.1 Global Enteral Nutrition and Parenteral Nutrition Market Size Forecast by Region
12.1.1 Global Enteral Nutrition and Parenteral Nutrition Forecast by Region (2025-2030)
12.1.2 Global Enteral Nutrition and Parenteral Nutrition Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enteral Nutrition and Parenteral Nutrition Forecast by Type
12.7 Global Enteral Nutrition and Parenteral Nutrition Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.1.3 Abbott Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 B. Braun
13.2.1 B. Braun Company Information
13.2.2 B. Braun Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.2.3 B. Braun Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 B. Braun Main Business Overview
13.2.5 B. Braun Latest Developments
13.3 Baxter
13.3.1 Baxter Company Information
13.3.2 Baxter Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.3.3 Baxter Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Baxter Main Business Overview
13.3.5 Baxter Latest Developments
13.4 BBCA Pharmaceutical
13.4.1 BBCA Pharmaceutical Company Information
13.4.2 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.4.3 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BBCA Pharmaceutical Main Business Overview
13.4.5 BBCA Pharmaceutical Latest Developments
13.5 Biokin Pharmaceutical
13.5.1 Biokin Pharmaceutical Company Information
13.5.2 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.5.3 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biokin Pharmaceutical Main Business Overview
13.5.5 Biokin Pharmaceutical Latest Developments
13.6 China Meheco Kangli
13.6.1 China Meheco Kangli Company Information
13.6.2 China Meheco Kangli Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.6.3 China Meheco Kangli Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 China Meheco Kangli Main Business Overview
13.6.5 China Meheco Kangli Latest Developments
13.7 Cisen
13.7.1 Cisen Company Information
13.7.2 Cisen Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.7.3 Cisen Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cisen Main Business Overview
13.7.5 Cisen Latest Developments
13.8 Danone
13.8.1 Danone Company Information
13.8.2 Danone Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.8.3 Danone Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Danone Main Business Overview
13.8.5 Danone Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.9.3 Fresenius Kabi Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
13.10 Grand Life Sciences
13.10.1 Grand Life Sciences Company Information
13.10.2 Grand Life Sciences Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.10.3 Grand Life Sciences Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Grand Life Sciences Main Business Overview
13.10.5 Grand Life Sciences Latest Developments
13.11 Haisco Pharmaceutical Group
13.11.1 Haisco Pharmaceutical Group Company Information
13.11.2 Haisco Pharmaceutical Group Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.11.3 Haisco Pharmaceutical Group Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Haisco Pharmaceutical Group Main Business Overview
13.11.5 Haisco Pharmaceutical Group Latest Developments
13.12 JW Pharmaceutical
13.12.1 JW Pharmaceutical Company Information
13.12.2 JW Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.12.3 JW Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 JW Pharmaceutical Main Business Overview
13.12.5 JW Pharmaceutical Latest Developments
13.13 Kelun Pharma
13.13.1 Kelun Pharma Company Information
13.13.2 Kelun Pharma Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.13.3 Kelun Pharma Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Kelun Pharma Main Business Overview
13.13.5 Kelun Pharma Latest Developments
13.14 King York
13.14.1 King York Company Information
13.14.2 King York Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.14.3 King York Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 King York Main Business Overview
13.14.5 King York Latest Developments
13.15 Lionco Pharmaceutical
13.15.1 Lionco Pharmaceutical Company Information
13.15.2 Lionco Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.15.3 Lionco Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Lionco Pharmaceutical Main Business Overview
13.15.5 Lionco Pharmaceutical Latest Developments
13.16 Lummy
13.16.1 Lummy Company Information
13.16.2 Lummy Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.16.3 Lummy Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Lummy Main Business Overview
13.16.5 Lummy Latest Developments
13.17 Medisan
13.17.1 Medisan Company Information
13.17.2 Medisan Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.17.3 Medisan Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Medisan Main Business Overview
13.17.5 Medisan Latest Developments
13.18 Medtrition
13.18.1 Medtrition Company Information
13.18.2 Medtrition Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.18.3 Medtrition Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Medtrition Main Business Overview
13.18.5 Medtrition Latest Developments
13.19 Nestlé S.A.
13.19.1 Nestlé S.A. Company Information
13.19.2 Nestlé S.A. Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.19.3 Nestlé S.A. Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Nestlé S.A. Main Business Overview
13.19.5 Nestlé S.A. Latest Developments
13.20 Otsuka Pharmaceutical
13.20.1 Otsuka Pharmaceutical Company Information
13.20.2 Otsuka Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.20.3 Otsuka Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Otsuka Pharmaceutical Main Business Overview
13.20.5 Otsuka Pharmaceutical Latest Developments
13.21 Pfizer
13.21.1 Pfizer Company Information
13.21.2 Pfizer Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.21.3 Pfizer Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Pfizer Main Business Overview
13.21.5 Pfizer Latest Developments
13.22 Teva Pharmaceutical
13.22.1 Teva Pharmaceutical Company Information
13.22.2 Teva Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.22.3 Teva Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Teva Pharmaceutical Main Business Overview
13.22.5 Teva Pharmaceutical Latest Developments
13.23 Xi'an Libang Pharmaceutical
13.23.1 Xi'an Libang Pharmaceutical Company Information
13.23.2 Xi'an Libang Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Portfolios and Specifications
13.23.3 Xi'an Libang Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Xi'an Libang Pharmaceutical Main Business Overview
13.23.5 Xi'an Libang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
*If Applicable.